Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02887638
Other study ID # PHA-2016
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 8, 2018
Est. completion date May 18, 2020

Study information

Verified date May 2020
Source Hasselt University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Diagnosing and treating posture-related headache (PRH), such as tension-type and cervicogenic headache, is seriously hampered because of common features and complex interaction of the neurological and musculoskeletal system. Current therapies are therefore not as effective and the population of patients with PRH keeps on increasing. The diagnostic as well as the therapeutic process need more structure in order to select the most effective treatment; thereby contributing to preventive measures. This goal can be achieved through fundamental research with a clinically oriented background. Our study starts from a clinical problem, with a growing incidence, and is therefore highly relevant. Because sitting-posture seems to play an important role in PRH, the first step in the diagnostic process is to analyse postural differences between a PRH- and a control-group. In addition, the role of the dura mater in the headache-process will be examined. Patients with PRH will be classified in homogeneous groups based on these results. In a second phase individual-specific treatment programs will be composed. The general treatment-approach of postural abnormalities in the past failed because of the heterogeneous patient-populations. Sub-classifying musculoskeletal problems has been proven to be successful in the past (O'Sullivan & Dankaerts, non-specific low back pain).

Our study is divided in 2 phases:

- phase 1: profile analysis (no intervention, experimental headache-group vs. asymptomatic controls)

- phase 2: interventional phase (clustered headache-groups, based on the results of phase 1


Recruitment information / eligibility

Status Completed
Enrollment 36
Est. completion date May 18, 2020
Est. primary completion date May 18, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria Headache-group:

1. Males and females between 20 and 50 years

2. Confirmed medical diagnosis of tension-type headache, cervicogenic headache or a mixture

3. Headache can be provoked by awkward cervical and/or head postures

Exclusion Criteria Headache-group:

1. Pregnancy

2. History of pericranial surgery

3. Serious pathology (neurological/cardiovascular/endocrine/musculoskeletal)

4. Red flags

5. Physical or manual therapy treatment for headache < 4 weeks prior the study

6. Excessive (> 10 days/month for > 3 months) use of: ergotamine, NSAID's, opioids, triptans, acetylsalicylic acid and simple analgesics

7. Psychiatric comorbidity

8. Visual or temporo-mandibular dysfunction

Inclusion Criteria Control-group:

1. Males and females between 20 and 50 years

2. Asymptomatic, no headache-history

Exclusion Criteria Control-group:

1. Pregnancy

2. History of pericranial surgery

3. Excessive (> 10 days/month for > 3 months) use of: ergotamine, NSAID's, opioids, triptans, acetylsalicylic acid and simple analgesics

4. Visual or temporo-mandibular dysfunction

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Individual Profile Analysis (Physical therapy Intervention)
The Individual Profile Analysis consists of the following components: Analysis of the sitting-posture profile: o cervical spine, thoracic spine, lumbar spine and pelvis during a longitudinal provoking task (working at a laptop). Analysis of the dural profile before and after the provoking task: o Determination of the dural sensitivity by the use of the slump-test Analysis of the pain profile before and after the provoking task: Determination of pressure pain sensitivity by the use of pressure algometry Determination of the influence of pain on the quality of life by the use of the HIT-6 questionnaire

Locations

Country Name City State
Belgium Ziekenhuis Oost-Limburg Genk
Belgium Jessa Ziekenhuis Hasselt
Belgium Leuven University Leuven
Netherlands Zuyd University Heerlen
Netherlands Orbis Medisch Centrum Sittard

Sponsors (7)

Lead Sponsor Collaborator
Hasselt University Algemeen Ziekenhuis Vesalius, Jessa Hospital, KU Leuven, Orbisch Medisch Centrum, Ziekenhuis Oost-Limburg, Zuyd University of Applied Sciences

Countries where clinical trial is conducted

Belgium,  Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sitting-posture-profile Sitting-posture will be measured with a 3D-video analysis (Bonita, ©Vicon Motion Systems Ltd. UK). Markers are placed on specific anatomical reference points on the participant. Afterwards angles (°) will be automatically calculated (Nexus, ©Vicon Motion Systems Ltd. UK) day 1
Primary Pain-Profile 'Pain Pressure Threshold' will be measured. Through pressure- algometry (a) 'Pressure Pain Detection Threshold' (kPa/cm²) and (b) 'Pressure Pain Tolerance' (sec) will be determined (Somedic Sales AB, Stockholm Sweden). day 1
Primary Sitting-posture-profile Sitting-posture will be measured with a 3D-video analysis (Bonita, ©Vicon Motion Systems Ltd. UK). Markers are placed on specific anatomical reference points on the participant. Afterwards angles (°) will be automatically calculated (Nexus, ©Vicon Motion Systems Ltd. UK) week 1 up to week 8
Secondary Headache-related medication-use, headache intensity, duration and frequency. Through the use of a specific diary the secondary outcomes will be evaluated. week -4 up to week 8
Secondary Impact of headache on the quality of life. The 'Headache Impact Test (HIT-6)' will be used. week -4 up to week 8
See also
  Status Clinical Trial Phase
Withdrawn NCT03472872 - A Comparative Efficacy Trial of IV Acetaminophen Versus IV Ketorolac for Emergency Department Treatment of Generalized Headache Phase 4
Withdrawn NCT05410366 - Safe Harbors in Emergency Medicine, Specific Aim 3
Withdrawn NCT02866084 - Neuromodulation Treatment of Vestibular Migraines N/A
Active, not recruiting NCT03537573 - Provider-Targeted Behavioral Interventions to Prevent Unsafe Opioid Prescribing for Acute Pain in Primary Care N/A
Recruiting NCT05891808 - miR-155 Expression in Episodic and Chronic Migraine
Not yet recruiting NCT04352218 - Safety Profile of PETALO CVS in the Treatment of Non-thrombotic Internal Jugular Vein Stenosis and Chronic Headache Phase 2
Completed NCT02734992 - Acceptance and Commitment Therapy vs Medical Treatment as Usual Wait-list Control for Primary Headache Sufferers N/A
Completed NCT01327118 - Prostaglandin F2alpha in a Human Headache Model N/A
Completed NCT01153789 - Study of Oculomotor Dysfunction Leading to Children Vertigo N/A
Not yet recruiting NCT00969995 - Identification of Inflammatory Markers in Migraine Patients N/A
Not yet recruiting NCT00752921 - Randomized Placebo Controlled Trial With Etoricoxib That is Taken to Prevent the Yom Kippur Headache Phase 4
Completed NCT00212810 - Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache. Phase 4
Terminated NCT00291395 - PGI2 Induced Headache and Cerebral Haemodynamics in Healthy Volunteers Phase 1
Completed NCT00263094 - An End to the Yom Kippur (and Ramadan) Headache N/A
Completed NCT00135122 - Prednisolone in the Treatment of Withdrawal Headache in Probable Medication Overuse Headache Phase 3
Completed NCT02475005 - An Intervention to Improve Adolescent Headache Self-management N/A
Completed NCT03163901 - The Effect of OMT on Functional Outcomes and Anti-inflammatory Biomarkers in Mild to Moderate Traumatic Brain Injury N/A
Completed NCT01664585 - Exercise Training With Physically Active Lifestyle to Reduce Headache and Quality of Life N/A
Completed NCT04632420 - Evaluation of Headache and Childbirth in a Chronic Pain Population
Recruiting NCT05033613 - Home Blood Pressure Monitoring Before and After COVID-19 Vaccination in Patients at High Risk of Cardiovascular Disease